Skip to search formSkip to main contentSkip to account menu

Thaliblastine

Known as: Taliblastine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
SummaryThe antiproliferative activity of the non-myelotoxic antitumour agent of plant origin, Thaliblastine, on two human glioma… 
2005
2005
The non-myelotoxic antitumor drug thaliblastine (thalicarpine, NSC-68075, CAS-5373-42-21) has a novel chemical structure; it is a… 
1996
1996
The reversing effect of p-glycoprotein (Pgp) inhibitors on the multidrug resistance (MDR) phenotype is well established in a… 
1995
1993
1993
The effect of thaliblastine (TBL, NSC-68075), a plant alkaloid, in over-coming multidrug resistance was investigated in… 
1993
1993
Drug resistance severely limits the effectiveness of clinical cancer chemotherapy. Employment of drugs other than the selected… 
1982
1982
The incorporation of the antitumor alkaloid thaliblastine in liposomes greatly enhances its cytotoxicity in Walker S and TLX-5… 
1980
1980
Cyclophosphamide (CY) was tested in combination with the thalictrum alkaloid named thaliblastine (TBL) for therapeutic activity… 
1977
1977
The toxic action of the antiphlogistic drug thaliblastin, containing 93-95 per cent of the alcaloid thalicarpine was investigated… 
1976
1976
The antitumour activity of the alkaloid thaliblastine was studied on 7 ascitic and solid transplantable tumours in mice. It was…